Zobrazeno 1 - 10
of 82
pro vyhledávání: '"лизиноприл"'
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 89-92 (2018)
Изучено влияние НПВС на антигипертензивную активность различных иАПФ у больных артериальной гипертензией.
Externí odkaz:
https://doaj.org/article/11dd919c2f2d4e05b6566b0569d4e94e
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 32-36 (2018)
Опиожности применения описана фармакокинетика ингибиторов АПФ, возможности применения лизиноприла при заболеваниях печени и возрастн
Externí odkaz:
https://doaj.org/article/52a00fdf3994425ba30efc10b1ed83e7
Autor:
E. A. Ryabikhin, M. E. Mozheiko
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 6, Pp 25-28 (2016)
Aim. To compare the antihypertensive and metabolic effects of combined therapy (carvedilol reception and «School of the hypertensive patient») with these of the carvedilol monotherapy in young patients with arterial hypertension (HT) of 1-2 degrees
Externí odkaz:
https://doaj.org/article/120f8908f38c4f778c6ac92d0e35301c
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 2, Pp 55-58 (2016)
Aim. To study effect of antihypertensive drugs on quality of life (QoL) of patients with stable arterial hypertension (HT).Material and methods. Results of some studies with similar design involving totally 170 patients with HT, aged 57,2±8,8 y.o.,
Externí odkaz:
https://doaj.org/article/9d4bf993231e4be58347768830ed726e
Autor:
V. I. Podzolkov, K. K. Osadchy
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 1, Pp 57-62 (2016)
Approaches to the choice of antihypertensive pharmacotherapy are discussed. Evidence base of ACE inhibitor lisinopril is surveyed. Data about lisinopril effects on different endpoints, organoprotective action and advantages over other ACE inhibitors
Externí odkaz:
https://doaj.org/article/61bd0e208a984d239f78b15dc9cbb581
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 4, Pp 45-50 (2016)
Aim. Clinico-economical analysis of arterial hypertension (HT) treatmentMaterial and methods. 78 patients with HT were involved into the study. Patients were spitted into two groups depending on HT degree. The first group – 38 patients with HT 1 de
Externí odkaz:
https://doaj.org/article/742f38893ce74c4584044fb66f1c2f4b
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 3, Pp 14-18 (2016)
Aim. To evaluate parameters of arterial stiffness by non-invasive arteriography in patients with moderate/high cardiovascular risk receiving lisinopril and simvastatin.Material and methods. 20 patients (aged 50-55 y.o.) with arterial hypertension of
Externí odkaz:
https://doaj.org/article/0c29915dd5f64dc2960691c1620876a1
Autor:
L. A. Haisheva
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 2, Pp 27-32 (2016)
Aim. To study endothelial disorders and artery elasticity disorders in patients with arterial hypertension (HT), as well as possibility of their correction by lisinopril or by fixed low dose combination of lisinopril and hydrochlorothiazide.Material
Externí odkaz:
https://doaj.org/article/674b892be8284027ac70e33b8b08d50d
Autor:
N. P. Kutishenko, S. J. Martsevich
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 3, Iss 5, Pp 79-82 (2015)
Data of multicenter clinical trials on assessment of angiotensin converting enzyme inhibitor, lisinopril efficacy in therapy of patients with arterial hypertension, heart failure, myocardial infarction complicated with left ventricle dysfunction and
Externí odkaz:
https://doaj.org/article/0faa9da90dc341be82ef7b9a25f50ecb
Autor:
N. A. Dzhaiani
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 10, Iss 5, Pp 565-571 (2015)
Rationale and benefits of the use of the ACE inhibitor lisinopril in the clinical practice as an antihypertensive drug are considered. Special attention is paid to the organ protective effects of lisinopril and its application in some clinical situat
Externí odkaz:
https://doaj.org/article/9d826bffc6244a368a3bab273c8e3949